News
The Global Cosmetic Surgery Market achieved a valuation of $60.22 Billion in 2024 and is anticipated to exceed $136.55 ...
Dr. Ran Rubinstein Expands Regenerative Treatment Options With Ariessence Pure PDGF+ in Montvale, NJ
Ariessence Pure PDGF+ is now available at Rubinstein Plastic Surgery Center, offering topical and injectable applications to ...
Eramol, a UK-based pharmaceutical contract development and manufacturing organisation (CDMO), is pleased to announce ...
The Mammography Market is a dynamic segment within the global medical imaging industry, focused on the early detection and ...
Legal Matter/Strategic Company DecisionFDA Confirms Type B Meeting on Corticorelin Pivotal Phase 3 Study 31.07.2025 / 06:00 CET/CESTMEDIA RELEASELiestal, Switzerland– Curatis Holding AG (SIX: CURN) – ...
Edwards’ KONECT RESILIA Aortic Valved Conduit Receives CE Mark FOR COMPLEX AORTIC VALVE SURGERIESNEWBURY, July 25 2025 – Edwards Lifesciences today announced that it has received CE Mark for its ...
CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission (EC) has granted marketing authorization for the updated formulation of the ...
Reduce development timelines and costs, while improving access to life-saving treatments VANCOUVER, BC / ACCESS Newswire / July 30, 2025 / Onco-Innovations Limited (CBOE ...
Second Quarter Consolidated Revenues of $2.53 billion, up 5% on a Reported basis and 4% on an Organic (non-GAAP)1 basis over the prior year periodGAAP Net Income Attributable to Bausch Health ...
Black Book Report Highlights Total Cost of Ownership and Cybersecurity Threats as Primary Factors Influencing Shift Toward Affordable, Cloud-Based EHR Solutions TAMPA, FL / ACCESS Newswire / July 30, ...
MESA, ARIZONA / ACCESS Newswire / July 30, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE) is redefining the future of preventive healthcare with its cutting-edge AI Facial Age-Based Health Risk ...
SHELTON, CT / ACCESS Newswire / July 30, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results